Skip to main content
Top
Published in: American Journal of Clinical Dermatology 2/2000

01-03-2000 | Disease Management

α-Hydroxy Acid-Based Cosmetic Procedures

Guidelines For Patient Management

Authors: Rebecca C. Tung, Dr Wilma F. Bergfeld, Allison T. Vidimos, Berna K. Remzi

Published in: American Journal of Clinical Dermatology | Issue 2/2000

Login to get access

Abstract

α-Hydroxy acid (AHA) peels and home regimens have recently been recognized as important adjunctive therapy in a variety of conditions including photodamage, actinic damage, melasma, hyperpigmentation disorders, acne, and rosacea. Overall in our experience and in the literature, AHAs have a proven level of safety and efficacy in a variety of skin types. Although their exact mechanism of action is unknown, it has been demonstrated that AHAs improve these disorders by thinning the stratum corneum, promoting epidermolysis, dispersing basal layer melanin, and increasing collagen synthesis within the dermis.
In patients with photodamage, AHA peels and topical products are often combined with retinoids and other antioxidants for maximum benefit. Similarly, synergistic effects of fluorouracil and glycolic acid are observed in the treatment of diffuse actinic keratoses. For patients with melasma, AHA peels and combination products containing bleaching agents such as hydroquinone, kojic acid, and glycolic acid seem to have increased efficacy. Acne and rosacea patients can see improved results when standard regimens like antibacterials and topical retinoids are supplemented with AHA peels and lotions.
However, care should always be taken prior to commencing treatment with AHA peels and topical products. By obtaining a thorough history and physical examination, the physician will identify any specific factors like medications, prior procedures and medical conditions which can affect the outcome of the peel. During the interview, there should be open discussion of patient questions and concerns so that realistic expectations can be made. Pre- and post-peel regimens should also be reviewed in full as patient compliance is essential to ensure the success of a series of AHA peels.
Literature
1.
go back to reference Van Scott E.J., Liu R.J. Alpha hydroxy acids: procedures for use in clinical practice. Cutis 1989; 43: 222–228PubMed Van Scott E.J., Liu R.J. Alpha hydroxy acids: procedures for use in clinical practice. Cutis 1989; 43: 222–228PubMed
2.
go back to reference Bergfeld W., Tung R., Vidimos A., et al. Improving the appearance of photoaged skin with glycolic acid. J Am Acad Dermatol 1997; 36: 1011–1013PubMedCrossRef Bergfeld W., Tung R., Vidimos A., et al. Improving the appearance of photoaged skin with glycolic acid. J Am Acad Dermatol 1997; 36: 1011–1013PubMedCrossRef
3.
go back to reference Stiller N.J., Bartolone, Stern R., et al. Topical 8% glycolic acid and 8% L-lactic acid creams for the treatment of photoaged skin. Arch Dermatol 1996; 132: 631–635PubMedCrossRef Stiller N.J., Bartolone, Stern R., et al. Topical 8% glycolic acid and 8% L-lactic acid creams for the treatment of photoaged skin. Arch Dermatol 1996; 132: 631–635PubMedCrossRef
4.
go back to reference Perricone N.V., Dinardo J.C. Photoprotective and anti-inflammatory effects of topical glycolic acid. Dermatol Surg 1996; 22: 435–437PubMedCrossRef Perricone N.V., Dinardo J.C. Photoprotective and anti-inflammatory effects of topical glycolic acid. Dermatol Surg 1996; 22: 435–437PubMedCrossRef
5.
go back to reference Clark C.P. Alpha hydroxy acids in skin care. Clin Plast Surg 1996; 23: 49–56PubMed Clark C.P. Alpha hydroxy acids in skin care. Clin Plast Surg 1996; 23: 49–56PubMed
6.
go back to reference Dinardo J.C., Grove G.L., Moy L.S.. Clinical and histological effects of glycolic acid at different concentrations and pH levels. Dermatol Surg 1996; 22: 421–424PubMedCrossRef Dinardo J.C., Grove G.L., Moy L.S.. Clinical and histological effects of glycolic acid at different concentrations and pH levels. Dermatol Surg 1996; 22: 421–424PubMedCrossRef
7.
go back to reference Maddin S. Current review of alpha hydroxy acids. Skin Ther Lett 1998; 3: 1–2 Maddin S. Current review of alpha hydroxy acids. Skin Ther Lett 1998; 3: 1–2
8.
go back to reference Moy L.S., Howe K., Moy R.L.. Glycolic acid modulation of collagen production in human skin fibroblast cultures in vitro. Dermatol Surg 1996; 22: 439–441PubMedCrossRef Moy L.S., Howe K., Moy R.L.. Glycolic acid modulation of collagen production in human skin fibroblast cultures in vitro. Dermatol Surg 1996; 22: 439–441PubMedCrossRef
9.
go back to reference Kim S.J., Park J.H., Kim D.H., et al. Increased in vivo collagen synthesis and in vitro cell collagen synthesis and in vitro cell proliferative effect of glycolic acid. Dermatol Surg 1998; 24: 1054–1058PubMedCrossRef Kim S.J., Park J.H., Kim D.H., et al. Increased in vivo collagen synthesis and in vitro cell collagen synthesis and in vitro cell proliferative effect of glycolic acid. Dermatol Surg 1998; 24: 1054–1058PubMedCrossRef
10.
go back to reference Matarasso S.L., Hanke C.W., Alster T.S.. Cutaneous resurfacing. Dermatol Clin 1997; 135: 867–875 Matarasso S.L., Hanke C.W., Alster T.S.. Cutaneous resurfacing. Dermatol Clin 1997; 135: 867–875
11.
go back to reference Gilchrist B.A. A review of skin ageing and its medical therapy. Br J Dermatol 1996; 135: 867–875CrossRef Gilchrist B.A. A review of skin ageing and its medical therapy. Br J Dermatol 1996; 135: 867–875CrossRef
12.
go back to reference Lewis A.B., Gendler E.C.. Resurfacing with topical agents. Semin Cutan Med Surg 1996; 15: 139–144PubMedCrossRef Lewis A.B., Gendler E.C.. Resurfacing with topical agents. Semin Cutan Med Surg 1996; 15: 139–144PubMedCrossRef
13.
go back to reference Newman N., Newman A., Moy L.S., et al. Clinical improvement of photoaged skin with 50% glycolic acid. Dermatol Surg 1996; 22: 455–460PubMedCrossRef Newman N., Newman A., Moy L.S., et al. Clinical improvement of photoaged skin with 50% glycolic acid. Dermatol Surg 1996; 22: 455–460PubMedCrossRef
14.
go back to reference Murad H.,. Shamban A.T., Premo P.S. The use of glycolic acid as a peeling agent. Dermatol Clin 1995; 13: 285–307PubMed Murad H.,. Shamban A.T., Premo P.S. The use of glycolic acid as a peeling agent. Dermatol Clin 1995; 13: 285–307PubMed
15.
go back to reference Huilgol S.C., Carruthers A.,. Caruthers J.D. Raising eyebrows with botulinum toxin. Dermatol Surg 1999; 25: 373–375PubMedCrossRef Huilgol S.C., Carruthers A.,. Caruthers J.D. Raising eyebrows with botulinum toxin. Dermatol Surg 1999; 25: 373–375PubMedCrossRef
16.
go back to reference Klein A.W., Wexler P.,. Carruthers A.,. et al. Treatment of facial furrows and rhytides. Dermatol Clin 1997; 15: 595–607PubMedCrossRef Klein A.W., Wexler P.,. Carruthers A.,. et al. Treatment of facial furrows and rhytides. Dermatol Clin 1997; 15: 595–607PubMedCrossRef
17.
go back to reference Bolognia J.L. Dermatologic and cosmetic concerns of the older woman. Clin Geriatr Med 1993; 9: 209–229PubMed Bolognia J.L. Dermatologic and cosmetic concerns of the older woman. Clin Geriatr Med 1993; 9: 209–229PubMed
18.
go back to reference Marks R. Solar keratoses. Br J Dermatol 190; 122 Suppl. 35: 49-60 Marks R. Solar keratoses. Br J Dermatol 190; 122 Suppl. 35: 49-60
19.
20.
go back to reference Winton G.B., Lewis C.W. Dermatoses of pregnancy. J Am Acad Dermatol 1982; 66: 977–998CrossRef Winton G.B., Lewis C.W. Dermatoses of pregnancy. J Am Acad Dermatol 1982; 66: 977–998CrossRef
21.
go back to reference Garcia A.,. Fulton J.E. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg 1996; 22: 443–447PubMedCrossRef Garcia A.,. Fulton J.E. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg 1996; 22: 443–447PubMedCrossRef
22.
go back to reference Lim J.T.E., Tham S.N. Glycolic acid peels in the treatment of melasma among asian women. Dermatol Surg 1997; 23: 177–179PubMedCrossRef Lim J.T.E., Tham S.N. Glycolic acid peels in the treatment of melasma among asian women. Dermatol Surg 1997; 23: 177–179PubMedCrossRef
23.
go back to reference Van Scott E.J., Yu R.J. Alpha hydroxy acids: therapeutic potentials. Can J Dermatol1989; 1: 108–112 Van Scott E.J., Yu R.J. Alpha hydroxy acids: therapeutic potentials. Can J Dermatol1989; 1: 108–112
25.
go back to reference Goulden V.,. Clark S.M., Cunliffe W.J. Post-adolescent acne: review of clinical features.Br J Dermatol 1997; 136: 66–70PubMedCrossRef Goulden V.,. Clark S.M., Cunliffe W.J. Post-adolescent acne: review of clinical features.Br J Dermatol 1997; 136: 66–70PubMedCrossRef
26.
go back to reference Sperling L.,. Hermer W. Androgen biology as a basis for the diagnosis and treatment of androgenic disorders in women. J Am Acad Dermatol 1993; 28: 669–683PubMedCrossRef Sperling L.,. Hermer W. Androgen biology as a basis for the diagnosis and treatment of androgenic disorders in women. J Am Acad Dermatol 1993; 28: 669–683PubMedCrossRef
27.
28.
go back to reference Lucky A.W., Henderson T.A., Olson W.H., et al. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol. 1997; 37: 746–754PubMedCrossRef Lucky A.W., Henderson T.A., Olson W.H., et al. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol. 1997; 37: 746–754PubMedCrossRef
29.
go back to reference Plewig G., Jansen T. Rosacea. In: Freedberg I.M., Eisen A.Z., Wolff K., et al., editors. Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill, 1999: 785–794 Plewig G., Jansen T. Rosacea. In: Freedberg I.M., Eisen A.Z., Wolff K., et al., editors. Fitzpatrick’s dermatology in general medicine. New York: McGraw-Hill, 1999: 785–794
30.
go back to reference Bonnar E.,. Eustace P., Powell FC. Demodex mite population in rosacea. J Am Acad Dermatol 1993; 28: 443–448PubMedCrossRef Bonnar E.,. Eustace P., Powell FC. Demodex mite population in rosacea. J Am Acad Dermatol 1993; 28: 443–448PubMedCrossRef
31.
go back to reference Utas U.,. Ozbakin O.,. Turasan A., et al. Helicobacter pylori eradication treatment reduces severity of rosacea. J Am Acad Dermatol 1999; 40: 433–435PubMedCrossRef Utas U.,. Ozbakin O.,. Turasan A., et al. Helicobacter pylori eradication treatment reduces severity of rosacea. J Am Acad Dermatol 1999; 40: 433–435PubMedCrossRef
32.
go back to reference Bergfeld W.F., Remzi B.K., Green B., et al. Evaluation of gluconolactone sensitive skin care products [poster]. American Academy of Dermatology Meeting. 1998; Orlando (FL) Bergfeld W.F., Remzi B.K., Green B., et al. Evaluation of gluconolactone sensitive skin care products [poster]. American Academy of Dermatology Meeting. 1998; Orlando (FL)
33.
go back to reference Dahl M.V. Optimal strategies for the treatment of rosacea. Skin Aging 1999; 7: 44–48 Dahl M.V. Optimal strategies for the treatment of rosacea. Skin Aging 1999; 7: 44–48
34.
go back to reference Wang C.-M., Huang C.-L., Hu C.-T.S., et al. The effect of glycolic acid on the treatment of acne in asian skin. Dermatol Surg 1997; 23: 23–29PubMedCrossRef Wang C.-M., Huang C.-L., Hu C.-T.S., et al. The effect of glycolic acid on the treatment of acne in asian skin. Dermatol Surg 1997; 23: 23–29PubMedCrossRef
35.
go back to reference Duffy D.M. Alpha hydroxy acids / trichloroacetic acids risk / benefit strategies.Dermatol Surg 1998; 24: 181–189PubMedCrossRef Duffy D.M. Alpha hydroxy acids / trichloroacetic acids risk / benefit strategies.Dermatol Surg 1998; 24: 181–189PubMedCrossRef
36.
go back to reference Slavin J.W. Considerations in alpha hydroxy acid peels. Clin Plast Surg 1998; 25: 45–52PubMed Slavin J.W. Considerations in alpha hydroxy acid peels. Clin Plast Surg 1998; 25: 45–52PubMed
37.
go back to reference Kripke M. Ozone, photodamage, and photoprotection. Presented at the American Academy of Dermatology. 1998 Jul 31; Chicago (IL) Kripke M. Ozone, photodamage, and photoprotection. Presented at the American Academy of Dermatology. 1998 Jul 31; Chicago (IL)
39.
go back to reference Naylor M.F., Boyd A., Smith D.W., et al. High sun protection factor sunscreens in suppresion of actinic neoplasia. Arch Dermatol 1995; 131: 170–175PubMedCrossRef Naylor M.F., Boyd A., Smith D.W., et al. High sun protection factor sunscreens in suppresion of actinic neoplasia. Arch Dermatol 1995; 131: 170–175PubMedCrossRef
40.
go back to reference Bergfeld W.F., Fiume M.Z., Andersen F.A. Safety assessment of alpha hydroxy acid ingredients used in cosmetic products. Cleveland (OH): Cleveland Clinic Foundation, 1999 Bergfeld W.F., Fiume M.Z., Andersen F.A. Safety assessment of alpha hydroxy acid ingredients used in cosmetic products. Cleveland (OH): Cleveland Clinic Foundation, 1999
Metadata
Title
α-Hydroxy Acid-Based Cosmetic Procedures
Guidelines For Patient Management
Authors
Rebecca C. Tung
Dr Wilma F. Bergfeld
Allison T. Vidimos
Berna K. Remzi
Publication date
01-03-2000
Publisher
Springer International Publishing
Published in
American Journal of Clinical Dermatology / Issue 2/2000
Print ISSN: 1175-0561
Electronic ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200001020-00002

Other articles of this Issue 2/2000

American Journal of Clinical Dermatology 2/2000 Go to the issue

Adis New Drug Profile

Topical Aminolevulinic Acid HCL

Review Article

Alopecia Areata

Practical Dermatology

Diabetic Foot Ulcers

Adis New Drug Profile

Topical Aminolevulinic Acid HCl

Disease Management

Management of Hirsutism